High parental age at childbirth has repeatedly been linked to childhood malignancies, while few studies have focused on the offspring's risk of adult cancer. In this population-based case-control study, we identified 32,000 patients with lymphoid neoplasms, diagnosed at ages 0-79 years during the period 1987-2011, and 160,000 matched controls in Sweden. Using prospectively registered data on their first-degree relatives, we evaluated the impact of parental age on the risk of lymphoid neoplasms by subtype. Overall, each 5-year increment in maternal age was associated with a 3% increase in incidence of offspring lymphoid neoplasms (hazard ratio = 1.03, 95% confidence interval: 1.02, 1.04). The association was similar for paternal age and present even among individuals older than 70 years of age at diagnosis. Stratified analyses further revealed that the association was limited to certain subtypes, mostly of indolent nature. Risks of chronic lymphocytic leukemia, follicular lymphoma, and mantle cell lymphoma were 5%-10% higher per 5-year increment in maternal age, but no associations were observed for acute lymphoblastic leukemia, plasma cell neoplasms, or diffuse large B-cell lymphoma. These findings indicated that prenatal genetic or epigenetic changes influence risk of adult lymphoid neoplasms and suggest a difference in this association between aggressive and indolent lymphoma subtypes.
High parental age predisposes the offspring to several genetic diseases. The well-known maternal age effect on Down syndrome risk and the increased risk of X-linked diseases such as hemophilia in offspring with older fathers were already established in the 1950s (1) . Because cancer is a multiple-hit genetic disorder, cancer risk might also be affected by parental age. From studies on breast and testicular cancer, we know that risk factors acting early in life or even before birth can modify cancer risk several decades later (2, 3) . Most research on parental age and malignancy risk has, however, focused on childhood cancer. Leukemia in children and other childhood malignancies have been linked to high parental age in several, but not all, studies (4) (5) (6) (7) (8) . Regarding adult cancer, there is evidence of an association of parental age with risk of breast cancer (2) and of paternal age with risk of prostate cancer (9) .
Associations of parental age with risk of adult lymphoid malignancies have, to our knowledge, been observed only twice. In 2010, Lu et al. (10) reported an association between increasing paternal age and risk of lymphoma in the California Teachers Study. In 2012, Crump et al. (11) reported an increase in risk of non-Hodgkin lymphoma (NHL) among children and young adults with increasing maternal age. We aimed to investigate the possible relationship between parental age and incidence of lymphoid neoplasms, with special emphasis on lymphoid malignancy subtypes, in a nested population-based case-control study of more than 32,000 patients and 160,000 matched population controls in Sweden during a 25-year period.
Health and Welfare and Statistics Sweden. Because all Swedish citizens at birth or immigration are assigned a unique identification number, the registers can be cross-linked. In addition, the Swedish Total Population Register held by Statistics Sweden was used to select a matched control population (12) .
The Swedish Cancer Registry was founded in 1958 and covers all incident cancers in Sweden. Reporting is mandatory for both clinicians and pathologists, resulting in a near total completeness (13) . The register contains data on malignant diagnoses according to the International Classification of Diseases (ICD) and SNOMED codes (14) . Subtype-specific results in our study were based on these reported codes and not on renewed examination of the pathology specimen. However, experience from an earlier reevaluation of more than 2,000 Swedish lymphatic malignancies indicated that these codes are correct to a level of approximately 97% (15) .
The Multi-Generation Register is derived from Swedish population statistics and contains linkages and birthdates for parents, siblings, and children of all Swedish citizens born in 1932 or later and resident in Sweden at some point after January 1, 1961. Today, the overall completeness is 84% for mothers and 82% for fathers (16) . Missing data is more common among individuals born during the first decades recorded and among individuals born outside of Sweden. The completeness is also lower for deceased subjects.
For ascertainment of potential comorbidity, we used data from the National Patient Register. This register holds records of ICD-coded diagnoses from all hospital admissions. It has gradually expanded from the start in 1964 to cover all of Sweden from 1987 onward. Since 2001, diagnoses from specialized outpatient care have also been recorded (17) .
Identification of cases and controls
All patients born 1932 or later with a diagnosis of a lymphoid neoplasm (ICD, Seventh Revision, codes 200-204) between 1987 and 2011 were retrieved from the Cancer Registry. Patients born before 1932 could not be included as they were never included in the Multi-Generation Register. Hence, the oldest cases were aged 79 years at diagnosis (born 1932 (18, 19) . For each case, 5 controls were randomly selected among all citizens of the same sex, born the same calendar year as the case, and resident in Sweden and free from lymphoid neoplasms at the date of the case diagnosis.
Ascertainment of exposure and covariates
For both cases and controls, we retrieved information on years of birth of parents, siblings, and children. This resulted in information on mothers' year of birth for 83% of the cases (and 84% of the controls) and fathers' year of birth for 79% of the cases (and 80% of the controls). The data on siblings and children enabled adjustments for family size and age at first childbirth. We retrieved information about all previous malignancies for both cases and controls from the Cancer Registry, and personal history of rheumatoid arthritis, systemic lupus erythematosus, Sjögren syndrome, or systemic sclerosis from the Patient Register.
Statistical analysis
Because all controls were individually matched on follow-up time, the design can be viewed as a nested case-control study with the Swedish population as the underlying cohort. The data were analyzed with risk set-stratified Cox regression, and relative risks were estimated as hazard ratios with 95% confidence intervals. All P values were 2-sided, and a value below 0.05 was considered statistically significant. To be included in each analysis, exposure data needed to be complete for the case and at least 1 corresponding control. Hence, only 83% of the original case/control sets were included in analyses of maternal age and 79% in analyses of paternal age. In the multivariable analyses, we adjusted for all background variables independently associated with outcome. Potential confounding covariates used for matching (age and sex) were included in all models. Other potential confounders/mediators included age at first childbirth (in years: <25, 25-34, ≥35, or no children), number of siblings (0, 1, 2, 3, or ≥4), birth order (first, second, third, or later), previous malignancies (yes/no), and a previous record of autoimmune diseases (rheumatoid arthritis, systemic lupus erythematosus, Sjögren syndrome, systemic sclerosis, or any combination), of which number of siblings, birth order, previous malignancies, and autoimmune diseases (yes/no) were included in the final model. Possible effect-measure modification was analyzed by adding interaction terms to the Cox proportional hazards model and formally tested for significance using Wald tests. The association with parental age was assumed to be linear in the main analyses. To evaluate this assumption, we tested possible departure from linearity by estimating a model where parental age was included as a restricted cubic spline function (5 knots, including boundary knots). Because we anticipated an interdependence between maternal and paternal age in each childbirth, we used Pearson's correlation coefficient to analyze the correlation between maternal and paternal age. All analyses were performed with SAS, version 9.4 (SAS Institute, Inc., Cary, North Carolina).
Ethical considerations
The study was approved by the regional research ethics committee at Karolinska Institutet (2012/298-31/1 and 2012/2040-32). No informed consent was collected because all data were cross-linked at the registries and delivered deidentified to the researchers.
33,065 of these had their primary diagnosis during 1987-2011. From these, 741 individuals were excluded because their diagnoses, according to a more recent or complementary classification (e.g., SNOMED), were only suspected malignancies (332 cases) or benign lymphoproliferative disorders (388 cases) rather than an established lymphoma, or because they had conflicting codes (21 cases). The remaining 32,324 cases and 161,620 age-and sex-matched controls were considered for analysis.
Approximately 60% of the cases (n = 19,152) were of male sex (Table 1) . Median age at diagnosis was 32 years for Hodgkin lymphoma (HL) patients and 58 years for NHL patients, with a range of 0-79 years; 21,836 cases (68%) were older than 50 years at diagnosis and 4,034 (12%) were older than 70 years. Most cases were diagnosed during more recent years: 21,707 (67%) were diagnosed in 2000 or later, and 14,427 (45%) were diagnosed in 2005 or later.
Compared with controls, cases more often had a history of autoimmune diseases (1.9% of cases versus 0.9% of controls; P < 0.0001) and previous malignancies (9.7% versus 7.8%; P < 0.0001) ( Table 1) . Although cases were more likely than controls to have no siblings (28.8% versus 28.2%; P = 0.02), no clear relationship could be identified between number of siblings and lymphoma risk among individuals with at least 1 sibling (P for trend = 0.72). Also, cases more often had no children of their own at the time of diagnosis (27.9% versus 27.3%; P = 0.02), but age at first childbirth among parous individuals did not seem to matter for lymphoma risk (P = 0.86).
Increasing maternal and paternal age were both significantly associated with increases in risk of all lymphoid neoplasms; we observed a 3% risk increase per 5-year maternal age increment and 2% per 5-year paternal age increment (Table 2) . Results changed very little upon adjustment for possible confounders as well as potential mediating factors. Over the ages where most childbirths take place, the associations were close to linear in the spline function (Web Figure 1 , available at https://academic.oup.com/aje). The association remained significant when restricting the analysis to lymphoid neoplasms diagnosed at 50 years of age or older and also at age 70 years or older. Risk estimates were similar, although only borderline significantly elevated in the smaller group of pediatric cases (<18 years). The significant association with increasing maternal age was present among both sexes, although risk estimates among males were slightly higher (Table 2 ). There was, however, no statistically significant interaction, either between maternal age and sex (P = 0.36) or between paternal age and sex (P = 0.43), with regard to risk of lymphoid neoplasms overall.
As expected, maternal and paternal age were closely related, with a Pearson's r of 0.75. After adjustment for paternal age in the analysis of maternal age and lymphoma risk and vice versa, the maternal age association remained significant whereas the association between paternal age and risk of lymphoid malignancies was no longer significant (hazard ratio (HR) = 1.01; P = 0.40).
By subclass of lymphoid neoplasms, parental age was significantly associated with risk of B-cell but not T-cell NHL (Table 2) , although the latter group was much smaller. For HL, a significant association was detected with older age of fathers but not mothers. Because HL has a bimodal incidence curve by age, we further stratified according to diagnosis before or after age 45 years, but risk estimates were similar (for ages <45 years, HR maternal age = 1.03, 95% confidence interval (CI): 0.99, 1.07, and HR paternal age = 1.03, 95% CI: 0.99, 1.07; for ages ≥45 years, HR maternal age = 1.03, 95% CI: 0.97, 1.10, and HR paternal age = 1.04, 95% CI: 0.98, 1.09).
By subtype of B-cell NHL, increasing parental age was significantly associated with risk of chronic lymphocytic leukemia, mantle cell lymphoma, hairy cell leukemia, lymphoplasmacytic lymphoma/Waldenström macroglobulinemia, and follicular lymphoma (FL) ( Table 3) . Increasing maternal or paternal age was not associated with risk of acute lymphoblastic leukemia, marginal zone lymphoma (MZL), plasma cell neoplasms, diffuse large B-cell lymphoma, or Burkitt lymphoma/leukemia (Table 3) . In an exploratory analysis, risk was further stratified by sex of the offspring (Figure 1) . In this stratification, associations with maternal and paternal age were noted only among men for mantle cell lymphoma, hairy cell leukemia, lymphoplasmacytic lymphoma, and MZL. In chronic lymphocytic leukemia and FL, the association with maternal age was statistically significant only among women. The interactions between maternal or paternal age and the sex of the offspring were statistically significant for mantle cell lymphoma, where both maternal and paternal age increased the risk in male but not female offspring, and for MZL, where higher maternal age increased the risk in male but not female offspring.
DISCUSSION
We found a clear association between increasing parental age and risk of lymphoid neoplasms. From a clinical perspective, the findings are irrelevant because the absolute risk differences are small, and parental age is a challenging target for preventive measures. On the other hand, an association with parental age suggests that the risk of these malignancies is to some extent already determined at birth. From this perspective, it is even more interesting to find that the observed association is not confined to pediatric cases but is also present for lymphoma subtypes arising later in life, at 70 years of age or older. If these observations are correct, we must imagine a multiplehit etiology spanning over more than 7 decades. Apart from the strictly etiological interest, our data could also be viewed in relation to the general trend in society towards higher parental age at childbirth (20) and the hitherto largely unexplained increase in incidence of lymphatic malignancies (21), although this increase seems to have flattened out during recent decades (22, 23) .
The varying associations across lymphoma subtypes revealed an intriguing pattern. The highest hazard ratios were observed for the B-cell lymphoma subtypes traditionally classified as indolent (24) (chronic lymphocytic leukemia, FL, hairy cell leukemia, lymphoplasmacytic lymphoma, and mantle cell lymphoma (the latter being intermediate indolentaggressive)), whereas no association was detected for the aggressive subtypes (acute lymphoblastic leukemia (among adults), diffuse large B-cell lymphoma, or Burkitt leukemia/lymphoma). The findings indicate an interesting difference in the nature and timing of etiological determinants, suggesting that indolent subtypes may have a longer etiological induction period than aggressive subtypes.
To a large extent, our data confirm the previous findings from the California Teachers Study (10) . In that cohort, which was restricted to women, approximately 700 cases of lymphoid malignancies were identified, and a higher risk of NHL was observed in association with high paternal but not maternal age. In their subtype-specific analyses, risks of both FL and chronic lymphocytic leukemia were borderline significantly associated with high paternal age, but no association was noted between paternal age and risk of diffuse large B-cell lymphoma. Whereas Lu et al. (10) found no significant association between maternal age and lymphoma risk, we generally observed similar associations with maternal and paternal age. Hence, based on our data, we cannot safely say which is more important. Apart from Lu et al., few authors have explored parental age as a risk factor for adult hematological malignancies. Crump et al. (11) reported a higher risk of NHL but not HL (25) with increasing maternal age. Their studies, however, included only individuals younger than 37 years at diagnosis, and the majority of the cases were pediatric. In 2015, Teras et al. (26) reported an association between high paternal age (>35 years) and risk of any hematological malignancy; however, the association was noted only among cases without siblings. In 1999, Hemminki and Kyyrönen (27) found a borderline significant increase in risk of unspecified leukemia (ages 15-53 years) with increasing maternal age but no significant increase in risk of lymphoma.
As expected (21), we found more previous malignancies and autoimmune diseases among cases than controls. However, adjustment for these factors did not change the results and thus could not represent mediators of the observed association. More cases also did not have siblings compared with controls. Such a correlation has been reported before (28) but also the opposite-that having more siblings was associated with increased risk of NHL (29) . Slightly more cases than controls had no children of their own at the time of diagnosis/ match date, possibly due to more prior comorbidity among the cases. Nevertheless, adjustment for these factors in the multivariable models did not alter the estimates, either, and thus cannot explain our main findings.
It could be argued that more affluent individuals have children later in life, and that their children in turn inherit their socioeconomic background. This could have biased our results if socioeconomic status also predicts lymphoma incidence. However, most studies do not support such an association (21, 30) . HL is an exception, where young adult patients are more likely to have higher socioeconomic status (31, 32) , although it is uncertain whether such an association still exists for contemporaneous HL patients (33, 34) . Still, we found no association between parental age and the incidence of HL overall. Moreover, adjustment for other factors believed to be influenced by socioeconomic conditions, such as age at first birth and number of siblings, did not alter our results. Hence, we believe that residual confounding by parental socioeconomic status is marginal.
Parental age might also be inherited, or attitudes towards childbearing may be transferred between generations (35) . If reproductive history were to be linked to lymphoma risk, and children of older mothers in turn had children later in life, this could in part explain our findings. However, parental age at first offspring birth was not related to lymphoma risk in this analysis, in line with earlier studies on the subject (36, 37) . So, why would parental age affect the offspring at all? Our data demonstrate a correlation but do not provide insights into the mechanism, although causality is not unthinkable. Parental age effects is an area of intensive research, and a number of biological hypotheses have been put forward. Regarding paternal age effects, earlier researchers believed that these would be due to sporadic mutations in the spermatozoa (38) . Recent data intriguingly suggest that such mutations are in fact rare, but mutant sperms can in certain cases be positively selected and their mutations thereby amplified (39) . Advanced maternal age instead increases the risk of trisomy, perhaps due to oxidative stress, and of mitochondrial disorders (40) . Parental age, especially maternal, also correlates with the level of DNA methylation in the newborn (41, 42) , which in turn has been implicated in the etiology of B-cell neoplasms (43). Meanwhile, paternal age has been associated with leukocyte telomere length in the offspring (44, 45) , and a recent large study by the InterLymph consortium also supports the idea that increased leukocyte telomere length is associated with higher risk of lymphatic malignancies, especially chronic lymphatic leukemia (46) .
The analysis of parental age and risk of B-cell lymphoma subtypes according to sex (Figure 1) should be viewed as strictly exploratory. The pattern of associations of high parental age with FL among women-and with mantle cell lymphoma, MZL, hairy cell leukemia, and lymphoplasmacytic lymphoma among men-is intriguing, but it was not based on any biological a priori hypothesis. Further, the interaction reached statistical significance only for mantle cell lymphoma and MZL, and the analyses have not been corrected for multiple testing. However, the sex-stratified analyses could be motivated by the striking and so far unexplained differences in incidence by sex for most lymphoid neoplasms. Because the observed associations are small, our interpretations would be vulnerable to unmeasured confounding. In order to assess the possible role of such confounding, we performed a sensitivity analysis as described by Rothman (47) . In this analysis, the associations remained robust with infrequent confounding (prevalence below 10%), or with a moderate association with lymphoma risk (relative risk below 1.4), whereas a confounder that was both frequent and with a substantial association with the outcome could possibly explain the entire association (full data available on request).
The major strength of this study is its size and populationbased setting and the use of prospectively recorded data with high coverage. Because the observed associations are small, the size of the study was essential to properly address chance. Around one-fifth of both cases and controls had missing data on parental age, a little more on paternal age (20%) than on maternal age (17%). This fraction was approximately as expected, and is mostly due to missing data for individuals born in the earliest decades and for immigrants. Although it could have an impact on generalizability, it is unlikely to have biased our analyses because all comparisons were performed inside matched case-control strata with complete data. Our study was based on population statistics and basic registry data, so another drawback is our lack of tumor characteristics, histopathological review, and other clinical data. Future studies with inclusion of genetic data from the malignancies could provide valuable insights and help explain the associations. It should also be noted that our study was restricted to individuals aged 79 years or younger and thus it is unclear whether the results are valid for older lymphoma patients. In summary, we report a modest association between parental age and incidence of lymphoid neoplasms in the offspring. The findings indicated that the risk of adult lymphoma is to some extent determined prenatally. The data further indicated that the association exists primarily for indolent B-cell NHL subtypes. These findings encourage future studies in order to investigate potential genetic or epigenetic changes in adult indolent lymphoma that may already be present from birth. 
